/Passle/62189924f636e915f48daeda/MediaLibrary/Images/2025-03-06-19-05-46-760-67c9f20a163e71f7a94b7921.png)
Introduction: A Significant Shift in PTAB Discretionary Denials The United States Patent and Trademark Office (USPTO) has rescinded the...
/Passle/62189924f636e915f48daeda/MediaLibrary/Images/2025-02-06-06-15-36-898-67a453884f1402a3d0b7b02c.png)
Patent litigation is widely acknowledged as one of the most expensive and complex areas of dispute resolution. With stakes frequently...
/Passle/62189924f636e915f48daeda/MediaLibrary/Images/2025-01-16-01-13-31-740-67885d3bab56ae4f199c0520.png)
Ever wondered how to harness the power of AI without accidentally spilling your client's secrets all over the internet? If you're a...
/Passle/62189924f636e915f48daeda/SearchServiceImages/2024-07-29-16-28-17-687-66a7c321ed45137ff9172d7e.jpg)
On July 19, 2024, the U.K. Court of Appeal rejected a patent application by Emotional Perception AI Limited (EPL), essentially because...
/Passle/62189924f636e915f48daeda/SearchServiceImages/2024-10-30-22-38-44-286-6722b574b3126dda0b91d4e3.jpg)
Partner David Knight authored an article for Law360’s Expert Analysis section examining the Dec. 20 decision by the U.K. Supreme Court...
/Passle/62189924f636e915f48daeda/SearchServiceImages/2023-12-20-15-23-26-687-658306ee6416f9398a4cb33d.jpg)
Although not entirely unexpected, the Dec. 20 decision by the United Kingdom Supreme Court on the so-called Device for the Autonomous...
/Passle/62189924f636e915f48daeda/SearchServiceImages/2023-12-04-15-01-32-909-656de9cce107b08ae02826d4.jpg)
The High Court of Justice in London recently issued a judgment on the question of whether or not an artificial intelligence invention...
/Passle/62189924f636e915f48daeda/SearchServiceImages/2024-11-01-18-05-53-669-672518815d7b6f185f682a8c.jpg)
In an article for Thomson Reuters’ Westlaw Today, Partners Ian DiBernardo and Jason Sobel and Associate Marcus Strong examine a recent...
/Passle/62189924f636e915f48daeda/SearchServiceImages/2024-12-05-09-45-45-097-67517649543d00e4d896fd4d.jpg)
Adam Schoen and Robert Ruh co-authored an article examining the FDA’s guidance on clinical recommendations for “N of 1” gene therapies....
/Passle/62189924f636e915f48daeda/MediaLibrary/Images/2024-10-25-07-46-38-668-671b4cde1234385d3d195b1a.jpg)
Boston partner Edward Naughton authored, “New Patent Office Rule Creates Unpredictability in Patent Challenge,” published in Bloomberg...